Lopinavir (ABT-378) is a peptidomimetic HIV protease inhibitor that retains activity against HIV protease with the Val 82 mutation. Lopinavir is less affected by binding to serum proteins than the structurally-related drug ritonavir.
声明:
如果该化合物涉及专利保护,请勿作为商业目的使用,且仅供实验分析及研究之目的;如被销售到构成专利侵权的国家,则相应的一切风险将由买方承担。